137 related articles for article (PubMed ID: 36723852)
1. Identification of an Activating PDGFRA Deletion in a Novel Sinonasal Soft Tissue Neoplasm.
Watkins JA; Hatcher H; Malhotra S; Amen F; Bruty J; Trotman J; Tarpey P; Tadross JA
Head Neck Pathol; 2023 Jun; 17(2):576-580. PubMed ID: 36723852
[TBL] [Abstract][Full Text] [Related]
2. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.
Wasag B; Debiec-Rychter M; Pauwels P; Stul M; Vranckx H; Oosterom AV; Hagemeijer A; Sciot R
Mod Pathol; 2004 Aug; 17(8):889-94. PubMed ID: 15154005
[TBL] [Abstract][Full Text] [Related]
4. qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.
Fassunke J; Blum MC; Schildhaus HU; Zapatka M; Brors B; Künstlinger H; Büttner R; Wardelmann E; Merkelbach-Bruse S
BMC Mol Biol; 2010 Dec; 11():100. PubMed ID: 21171987
[TBL] [Abstract][Full Text] [Related]
5. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
7. Morphological Correlates of KIT and PDGFRA Genotypes in Gastrointestinal Stromal Tumour.
Priya V; Kumari N; Krishnani N
Turk Patoloji Derg; 2020; 36(2):116-125. PubMed ID: 31538651
[TBL] [Abstract][Full Text] [Related]
8. Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.
Kwon JE; Kang HJ; Kim SH; Lee YC; Hyung WJ; Noh SH; Kim NK; Kim H
Pathology; 2009; 41(6):544-54. PubMed ID: 19900103
[TBL] [Abstract][Full Text] [Related]
9. Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.
Agaram NP; Baren A; Arkun K; Dematteo RP; Besmer P; Antonescu CR
Ultrastruct Pathol; 2006; 30(6):443-52. PubMed ID: 17182437
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
11. Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTs.
Ricci R; Giustiniani MC; Gessi M; Lanza P; Castri F; Biondi A; Persiani R; Vecchio FM; Risio M
J Cell Mol Med; 2018 Oct; 22(10):4856-4862. PubMed ID: 30117724
[TBL] [Abstract][Full Text] [Related]
12. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
[TBL] [Abstract][Full Text] [Related]
13. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV
Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730
[TBL] [Abstract][Full Text] [Related]
15. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity.
Yi ES; Strong CR; Piao Z; Perucho M; Weidner N
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):157-61. PubMed ID: 15894928
[TBL] [Abstract][Full Text] [Related]
17. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential.
Kontogianni-Katsarou K; Dimitriadis E; Lariou C; Kairi-Vassilatou E; Pandis N; Kondi-Paphiti A
World J Gastroenterol; 2008 Mar; 14(12):1891-7. PubMed ID: 18350628
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
Bombac A; Zakotnik B; Bucic M; Setrajcic Dragos V; Gazic B; Stegel V; Klancar G; Novakovic S
Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
[TBL] [Abstract][Full Text] [Related]
19. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
20. Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases.
Lasota J; Wang ZF; Sobin LH; Miettinen M
Mod Pathol; 2009 Aug; 22(8):1049-56. PubMed ID: 19448595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]